These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21801427)

  • 21. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER2 and HER3 in HPV+ and HPV- HNSCC--Response.
    Grandis J
    Clin Cancer Res; 2016 Apr; 22(7):1826. PubMed ID: 27037255
    [No Abstract]   [Full Text] [Related]  

  • 23. HER2 and HER3 in HPV+ and HPV- HNSCC--Letter.
    Machiels JP; Galot R; Schmitz S
    Clin Cancer Res; 2016 Apr; 22(7):1825. PubMed ID: 27037254
    [No Abstract]   [Full Text] [Related]  

  • 24. Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
    Hu Z; Qian G; Müller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Lane K; Hoyt C; Shin DM; Chen ZG
    Oncotarget; 2016 Jul; 7(28):44676-44685. PubMed ID: 27172790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.
    Kadletz L; Heiduschka G; Wiebringhaus R; Gurnhofer E; Kotowski U; Haymerle G; Brunner M; Barry C; Kenner L
    Cell Oncol (Dordr); 2017 Apr; 40(2):193-198. PubMed ID: 28039609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
    Alvarado D; Ligon GF; Lillquist JS; Seibel SB; Wallweber G; Neumeister VM; Rimm DL; McMahon G; LaVallee TM
    PLoS One; 2017; 12(7):e0181356. PubMed ID: 28723928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
    Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
    Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
    Yamashita T; Shimada H; Tanaka S; Araki K; Tomifuji M; Mizokami D; Tanaka N; Kamide D; Miyagawa Y; Suzuki H; Tanaka Y; Shiotani A
    Cancer Med; 2016 Mar; 5(3):415-25. PubMed ID: 26798989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients.
    Bae SY; La Choi Y; Kim S; Kim M; Kim J; Jung SP; Choi MY; Lee SK; Kil WH; Lee JE; Nam SJ
    Breast Cancer Res Treat; 2013 Jun; 139(3):741-50. PubMed ID: 23722313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment.
    Wang YF; Chang CJ; Chiu JH; Lin CP; Li WY; Chang SY; Chu PY; Tai SK; Chen YJ
    Oncotarget; 2014 Sep; 5(17):7392-405. PubMed ID: 25277180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.
    De Herdt MJ; Willems SM; van der Steen B; Noorlag R; Verhoef EI; van Leenders GJ; van Es RJ; KoljenoviÄ S; Baatenburg de Jong RJ; Looijenga LH
    Oncotarget; 2016 Mar; 7(11):13167-81. PubMed ID: 26909606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER3 overexpression and survival in solid tumors: a meta-analysis.
    Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
    J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
    Birkeland AC; Yanik M; Tillman BN; Scott MV; Foltin SK; Mann JE; Michmerhuizen NL; Ludwig ML; Sandelski MM; Komarck CM; Carey TE; Prince ME; Bradford CR; McHugh JB; Spector ME; Brenner JC
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):559-67. PubMed ID: 27077364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior.
    Chien CY; Tsai HT; Su LJ; Chuang HC; Shiu LY; Huang CC; Fang FM; Yu CC; Su HT; Chen CH
    Oncotarget; 2014 Apr; 5(8):2243-62. PubMed ID: 24810160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.